Anisakiasis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1070B81.0
Who is this for?
Show terms as
16Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Anisakiasis (also known as anisakidosis or herring worm disease) is a parasitic infection caused by the ingestion of larvae of nematodes belonging to the family Anisakidae, most commonly Anisakis simplex and Pseudoterranova decipiens. Humans become accidental hosts by consuming raw or undercooked seafood (such as sushi, sashimi, ceviche, or pickled fish) contaminated with third-stage larvae. The disease is not genetically inherited but is an acquired zoonotic infection. The larvae primarily affect the gastrointestinal system. After ingestion, the larvae can penetrate the mucosa of the stomach (gastric anisakiasis) or intestine (intestinal anisakiasis), causing acute symptoms including severe epigastric or abdominal pain, nausea, vomiting, and diarrhea, typically occurring within hours to days after consuming contaminated fish. In some cases, the larvae can trigger significant allergic reactions, including urticaria, angioedema, and even anaphylaxis. Chronic infection may lead to granuloma formation in the gastrointestinal wall, which can mimic tumors or Crohn's disease. Rarely, ectopic forms occur when larvae migrate to other tissues outside the gastrointestinal tract. Diagnosis is typically made through endoscopic visualization and removal of the larvae from the gastric or intestinal mucosa, or through histopathological examination of surgically removed tissue. Treatment of choice is endoscopic extraction of the larvae, which provides both diagnosis and cure. In cases where endoscopic removal is not possible, conservative management with supportive care may be employed, as the larvae cannot survive long-term in the human host. Albendazole has been used in some cases, though its efficacy is not well established. Prevention is the most effective strategy, involving thorough cooking of fish (to at least 60°C) or freezing at -20°C for at least 24 hours before consumption. The disease is most prevalent in regions where raw fish consumption is common, particularly Japan, but cases are increasingly reported in Europe, South America, and other regions worldwide.

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Anisakiasis.

View clinical trials →

No actively recruiting trials found for Anisakiasis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Anisakiasis community →

Specialists

16 foundView all specialists →
EC
Eun Joo Cha
FAIRFAX, VA
Specialist
1 Anisakiasis publication
IB
Ilaria Bellini
Specialist
3 Anisakiasis publications
SD
Stefano D'Amelio
Specialist
3 Anisakiasis publications
HS
Hiromu Sugiyama
Specialist
2 Anisakiasis publications
YM
Yasuyuki Morishima
Specialist
2 Anisakiasis publications
FA
Francisco Javier Adroher
Specialist
1 Anisakiasis publication
SC
Serena Cavallero
Specialist
3 Anisakiasis publications
MM
Manuel Morales-Yuste
Specialist
1 Anisakiasis publication
RB
Rocío Benítez
Specialist
1 Anisakiasis publication
TM
Tomohiko Mannami
Specialist
1 Anisakiasis publication
GI
Genyo Ikeda
Specialist
1 Anisakiasis publication
NF
Nobukiyo Fujiwara
Specialist
1 Anisakiasis publication
RP
R Fornell Pérez
Specialist
1 Anisakiasis publication
MG
M Urizar Gorosarri
Specialist
1 Anisakiasis publication
MB
M Pérez Bea
Specialist
1 Anisakiasis publication
EM
Emmanuel DUTOIT, MD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Anisakiasis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open AnisakiasisForum →

No community posts yet. Be the first to share your experience with Anisakiasis.

Start the conversation →

Latest news about Anisakiasis

No recent news articles for Anisakiasis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Anisakiasis

What is Anisakiasis?

Anisakiasis (also known as anisakidosis or herring worm disease) is a parasitic infection caused by the ingestion of larvae of nematodes belonging to the family Anisakidae, most commonly Anisakis simplex and Pseudoterranova decipiens. Humans become accidental hosts by consuming raw or undercooked seafood (such as sushi, sashimi, ceviche, or pickled fish) contaminated with third-stage larvae. The disease is not genetically inherited but is an acquired zoonotic infection. The larvae primarily affect the gastrointestinal system. After ingestion, the larvae can penetrate the mucosa of the stomach

Which specialists treat Anisakiasis?

16 specialists and care centers treating Anisakiasis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.